Cargando…
The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals
BACKGROUND: Variations within the FOXA family have been studied for a putative contribution to the risk of type 2 diabetes (T2D), and recently the minor T-allele of FOXA2 rs1209523 was reported to associate with decreased fasting plasma glucose levels in a study using a weighted false discovery rate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344680/ https://www.ncbi.nlm.nih.gov/pubmed/22325233 http://dx.doi.org/10.1186/1471-2350-13-10 |
_version_ | 1782232047005204480 |
---|---|
author | Banasik, Karina Hollensted, Mette Andersson, Ehm Sparsø, Thomas Sandbæk, Annelli Lauritzen, Torsten Jørgensen, Torben Witte, Daniel R Pedersen, Oluf Hansen, Torben |
author_facet | Banasik, Karina Hollensted, Mette Andersson, Ehm Sparsø, Thomas Sandbæk, Annelli Lauritzen, Torsten Jørgensen, Torben Witte, Daniel R Pedersen, Oluf Hansen, Torben |
author_sort | Banasik, Karina |
collection | PubMed |
description | BACKGROUND: Variations within the FOXA family have been studied for a putative contribution to the risk of type 2 diabetes (T2D), and recently the minor T-allele of FOXA2 rs1209523 was reported to associate with decreased fasting plasma glucose levels in a study using a weighted false discovery rate control procedure to enhance the statistical power of genome wide association studies in detecting associations between low-frequency variants and a given trait. Thus, the primary aim of this study was to investigate whether the minor T-allele of rs1205923 in FOXA2 associated with 1) decreased fasting plasma glucose and 2) a lower risk of developing T2D. Secondly, we investigated whether rs1205923 in FOXA2 associated with other glucose-related phenotypes. METHODS: The variant was genotyped in Danish individuals from four different study populations using KASPar(® )PCR SNP genotyping system. We examined for associations of the FOXA2 genotype with fasting plasma glucose and estimates of insulin release and insulin sensitivity following an oral glucose tolerance test in 6,162 Danish individuals from the population-based Inter99 study while association with T2D risk was assessed in 10,196 Danish individuals including four different study populations. RESULTS: The FOXA2 rs1209523 was not associated with fasting plasma glucose (effect size (β) = -0.03 mmol/l (95%CI: -0.07; 0.01), p = 0.2) in glucose-tolerant individuals from the general Danish population. Furthermore, when employing a case-control setting the variant showed no association with T2D (odds ratio (OR) = 0.82 (95%CI: 0.62-1.07), p = 0.1) among Danish individuals. However, when we performed the analysis in a subset of 6,022 non-obese individuals (BMI < 30 kg/m(2)) an association with T2D was observed (OR = 0.68 (95%CI: 0.49-0.94), p = 0.02). Also, several indices of insulin release and β-cell function were associated with the minor T-allele of FOXA2 rs1209523 in non-obese individuals. CONCLUSIONS: We failed to replicate association of the minor T-allele of FOXA2 rs1209523 with fasting plasma glucose in a population based sample of glucose tolerant individuals. More extensive studies are needed in order to fully elucidate the potential role of FOXA2 in glucose homeostasis. |
format | Online Article Text |
id | pubmed-3344680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33446802012-05-05 The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals Banasik, Karina Hollensted, Mette Andersson, Ehm Sparsø, Thomas Sandbæk, Annelli Lauritzen, Torsten Jørgensen, Torben Witte, Daniel R Pedersen, Oluf Hansen, Torben BMC Med Genet Research Article BACKGROUND: Variations within the FOXA family have been studied for a putative contribution to the risk of type 2 diabetes (T2D), and recently the minor T-allele of FOXA2 rs1209523 was reported to associate with decreased fasting plasma glucose levels in a study using a weighted false discovery rate control procedure to enhance the statistical power of genome wide association studies in detecting associations between low-frequency variants and a given trait. Thus, the primary aim of this study was to investigate whether the minor T-allele of rs1205923 in FOXA2 associated with 1) decreased fasting plasma glucose and 2) a lower risk of developing T2D. Secondly, we investigated whether rs1205923 in FOXA2 associated with other glucose-related phenotypes. METHODS: The variant was genotyped in Danish individuals from four different study populations using KASPar(® )PCR SNP genotyping system. We examined for associations of the FOXA2 genotype with fasting plasma glucose and estimates of insulin release and insulin sensitivity following an oral glucose tolerance test in 6,162 Danish individuals from the population-based Inter99 study while association with T2D risk was assessed in 10,196 Danish individuals including four different study populations. RESULTS: The FOXA2 rs1209523 was not associated with fasting plasma glucose (effect size (β) = -0.03 mmol/l (95%CI: -0.07; 0.01), p = 0.2) in glucose-tolerant individuals from the general Danish population. Furthermore, when employing a case-control setting the variant showed no association with T2D (odds ratio (OR) = 0.82 (95%CI: 0.62-1.07), p = 0.1) among Danish individuals. However, when we performed the analysis in a subset of 6,022 non-obese individuals (BMI < 30 kg/m(2)) an association with T2D was observed (OR = 0.68 (95%CI: 0.49-0.94), p = 0.02). Also, several indices of insulin release and β-cell function were associated with the minor T-allele of FOXA2 rs1209523 in non-obese individuals. CONCLUSIONS: We failed to replicate association of the minor T-allele of FOXA2 rs1209523 with fasting plasma glucose in a population based sample of glucose tolerant individuals. More extensive studies are needed in order to fully elucidate the potential role of FOXA2 in glucose homeostasis. BioMed Central 2012-02-12 /pmc/articles/PMC3344680/ /pubmed/22325233 http://dx.doi.org/10.1186/1471-2350-13-10 Text en Copyright © 2012 Banasik et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Banasik, Karina Hollensted, Mette Andersson, Ehm Sparsø, Thomas Sandbæk, Annelli Lauritzen, Torsten Jørgensen, Torben Witte, Daniel R Pedersen, Oluf Hansen, Torben The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title | The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title_full | The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title_fullStr | The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title_full_unstemmed | The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title_short | The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals |
title_sort | effect of foxa2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in danish individuals |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344680/ https://www.ncbi.nlm.nih.gov/pubmed/22325233 http://dx.doi.org/10.1186/1471-2350-13-10 |
work_keys_str_mv | AT banasikkarina theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT hollenstedmette theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT anderssonehm theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT sparsøthomas theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT sandbækannelli theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT lauritzentorsten theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT jørgensentorben theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT wittedanielr theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT pedersenoluf theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT hansentorben theeffectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT banasikkarina effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT hollenstedmette effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT anderssonehm effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT sparsøthomas effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT sandbækannelli effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT lauritzentorsten effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT jørgensentorben effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT wittedanielr effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT pedersenoluf effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals AT hansentorben effectoffoxa2rs1209523onglucoserelatedphenotypesandriskoftype2diabetesindanishindividuals |